STARR CHRISTOPHER M
Reporting owner on Forms 3, 4 and 5, CIK 1235470.
STARR CHRISTOPHER M reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Monopar Therapeutics CIK 1645469 | director | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Monopar Therapeutics Common Stock | 2026-10-01 | M exercised | +8,400 | $0.005 | 13,573 | Form 4 |
| Monopar Therapeutics Common Stock | 2026-10-01 | S sold | -4,631 | $78.09 | 8,942 | Form 4 |
| Monopar Therapeutics Common Stock | 2026-10-01 | S sold | -2,970 | $78.82 | 5,972 | Form 4 |
| Monopar Therapeutics Common Stock | 2026-10-01 | S sold | -799 | $79.67 | 5,173 | Form 4 |
| Monopar Therapeutics Common Stock, holding | 9,880 | Form 4 | ||||
| Monopar Therapeutics Stock Option, derivative | 2026-10-01 | M exercised | -8,400 | $0 | 8,400 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-032048 | Monopar Therapeutics | 2026-10-05 |